Article info
PDFHow to do it
Management of a wake-up stroke
- Correspondence to Dr Xuya Huang, Neurology, St George's Hospital, London SW17 0QT, UK; xuya.huang{at}nhs.net
Citation
Management of a wake-up stroke
Publication history
- Received December 17, 2018
- Revised January 11, 2019
- Accepted January 15, 2019
- First published March 14, 2019.
Online issue publication
June 23, 2020
Article Versions
- Previous version (23 June 2020).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.
Other content recommended for you
- Initial hospital management of patients with emergent large vessel occlusion (ELVO): report of the standards and guidelines committee of the Society of NeuroInterventional Surgery
- European Stroke Organisation (ESO)–European Society for Minimally Invasive Neurological Therapy (ESMINT) expedited recommendation on indication for intravenous thrombolysis before mechanical thrombectomy in patients with acute ischemic stroke and anterior circulation large vessel occlusion
- Advances in mechanical thrombectomy for acute ischaemic stroke
- Simplified selection criteria for patients with longer or unknown time to treatment predict good outcome after mechanical thrombectomy
- Management of acute ischemic stroke
- Outcome of multimodal MRI-guided intravenous thrombolysis in patients with stroke with unknown time of onset
- Acute stroke imaging selection for mechanical thrombectomy in the extended time window: is it time to go back to basics? A review of current evidence
- Does perfusion imaging add value compared with plain parenchymal and vascular imaging?
- Multicentre registration of wake-up stroke in China (MCRWUSC): a protocol for a prospective, multicentre, registry-based cohort study
- Rationale and design of Tenecteplase Reperfusion Therapy in Acute Ischaemic Cerebrovascular Events III (TRACE III): a randomised, phase III, open-label, controlled trial